Progenity Gets $125M in Financing to Speed Development of IBD Diagnostics, Therapeutics Platform
News
Progenity recently closed a $125 million financing round to accelerate development of its gastrointestinal (GI) platform for inflammatory bowel disease (IBD), including precision molecular diagnostic tools, precision therapeutics, microbiome analytics and ... Read more